Background and Aims: Sperm DNA integrity, concentration, and motility are suspected to be altered by thiopurines (azathioprine [AZA] and 6-mercaptopurine [6-MP]). We investigated the impact of thiopurines on semen quality in men with inflammatory bowel disease [IBD], by a comprehensive panel of semen analyses. Methods: Semen from 40 men with IBD, in remission on AZA/6-MP therapy, was prospectively collected and compared with samples from 40 healthy volunteers. Paired samples [off and on AZA/6-MP] were obtained from a subset of IBD patients, and blood and semen were collected to determine 6-MP transmission to the ejaculate. Sperm DNA fragmentation was evaluated via sperm chromatin structure assay [SCSA] [p = 0.72]. IBD patients on AZA/6-MP had significantly lower total and progressive sperm motility than healthy volunteers [48.5% versus 64.5%, p = 0.0003; 27.4% versus 43.3%, p = 0.0004; respectively], with no differences in concentration, volume, or morphology. The same trend was observed in the 10 paired samples. TGN incorporation was not detectable in sperm DNA, but 6-MP was detected in seminal plasma and correlated to blood levels [r s = 0.79, p = 0.02]. Conclusions: Thiopurines do not increase sperm DNA fragmentation but may impair sperm motility in this IBD cohort. Our findings support existing epidemiological data that thiopurine therapy is safe during preconception and should not be abandoned.
Introduction
Inflammatory bowel disease [IBD] affects patients during their reproductive age. 1 The potential impact of medical treatment on fertility and pregnancy outcomes remains an important clinical consideration. The thiopurines 6-mercaptopurine and azathioprine [AZA] are widely used in the treatment of IBD.
2 Downstream metabolites inhibit the de novo purine synthesis in somatic cells and cause mismatch DNA repair and DNA strand breaks. 3 It is debated whether thiopurines have an adverse effect on semen quality, 4 and consensus reports do not address the use of paternal thiopurine treatment in the preconception period. 5, 6 Simsek et al. 7 found no correlation between thiopurine therapy and semen quality or testicular function in a recent review of clinical studies, but concluded that existing data are insufficient for firm recommendations. In addition to a potential genotoxic effect during spermatogenesis, thiopurines could theoretically exert an adverse effect on the fetus through presence in the seminal fluid. 8 So far, no study has reported levels of thiopurines in human ejaculate.
Semen analysis is a cornerstone in the evaluation of male fertility, and the World Health Organization [WHO] has endorsed reference values including semen volume and sperm concentration, motility, and morphology. 9 However, the WHO classification does not evaluate the integrity of sperm DNA. The sperm chromatin structure assay [SCSA] detects existing DNA breaks as well as the susceptibility to acid-induced DNA denaturation, which occurs more often in fragmented DNA, 10 whereas the neutral Comet assay specifically detects double-stranded DNA breaks. 11 Normal sperm chromatin structure is essential for the correct transmission of paternal genetic information. Even with normal WHO parameters, spermatozoa may contain a high frequency of sperm DNA fragmentation. 12 DNA fragmentation in spermatozoa correlates negatively with the likelihood of achieving pregnancy, and fecundability starts declining when the SCSA parameter DNA fragmentation index [DFI] , a measure of spermatozoa with DNA fragmentation, is above 20%. 13, 14 Due to the mechanism of action, it is plausible that AZA/6-MP treatment may lead to DNA fragmentation in sperm and hence infertility.
We aimed to investigate the impact of AZA/6-MP treatment on semen quality in men with IBD. We applied WHO, SCSA, and Comet analyses to evaluate the conventional sperm parameters, as well as sperm DNA integrity. In addition, we investigated the incorporation of thioguanine nucleotides [TGNs] in sperm cell DNA and the levels of 6-MP in semen.
Methods

Study design and setting
The study was conducted at a tertiary IBD centre in Denmark. We prospectively included eligible participants who consented between November 2013 and August 2016. We performed three substudies: 1] we compared semen parameters between IBD patients on AZA/6-MP maintenance therapy and healthy volunteers; 2] we evaluated paired semen samples from a subgroup of the IBD patients who consented to sperm donation, both off and on AZA/6-MP treatment; and 3] we collected coupled blood and semen samples 0.5-2 h following AZA ingestion, to determine the degree of transmission of 6-MP via the seminal ejaculate.
Study population
Male patients who were 18-45 years of age, with an established diagnosis of Crohn's disease [CD] or ulcerative colitis [UC], were recruited from the outpatient clinic. Inclusion criteria were maintenance therapy with AZA or 6-MP during at least the previous 3 months, corresponding to the length of spermatogenesis. 15 Moreover, patients had to be in clinical remission for at least 3 consecutive months before sampling. Concomitant treatments with 5-aminosalicylic acid or anti-tumour necrosis factor-alpha [TNF-alpha] inhibitors were permitted.
In a subgroup of the IBD patients, we collected semen and blood samples either before initiation or cessation of AZA/6-MP treatment, for paired analysis of semen samples while off and on thiopurines. Healthy volunteers were first-time contacts recruited from Cryos International Sperm Bank, Aarhus, Denmark, and delivered one semen sample at their first visit to the sperm bank. In a separate study, a subgroup of IBD patients on stable AZA treatment delivered one sperm and blood sample at specific time points following ingestion of their usual dose of AZA, for the detection of 6-MP in seminal plasma.
Clinical data
All participants completed a general questionnaire with information on smoking status, alcohol intake, history of sexually transmitted diseases, and delayed descensus. Disease phenotype was classified according to the Montreal Classifications for both UC and CD. 16 The treating gastroenterologist recorded the Harvey-Bradshaw Index [HBI] for CD patients and the Simple Clinical Colitis Activity Index [SCCAI] for UC patients on the day when patients delivered samples.
17,18
Semen analyses
Patients were asked to abstain from sexual activity for a minimum of 2 and a maximum of 7 days. 9, 19 The sample was delivered by masturbation into a wide-mouth plastic cup. The semen samples were analysed according to the WHO 5th edition 2010 recommendations for evaluating semen volume and sperm concentration, motility, and morphology. 9 Spermatozoa were characterized as progressively motile [PR] , non-progressively motile [NP] , and immotile, and are expressed as percentages. Sperm smears for morphology assessment were analysed by Kruger's strict criteria by a single trained technologist. Sperm DNA fragmentation was assessed by the SCSA and neutral Comet assay, essentially according to the protocols previously described. 10, 20 Briefly, SCSA is a flow cytometric technique that measures the susceptibility of sperm DNA to acid-induced DNA denaturation, followed by staining with the fluorescent dye acridine orange. When excited by a blue light, acridine orange-intercalated, double-stranded DNA emits green fluorescence, whereas acridine orange associated with single-stranded DNA emits red fluorescence. More than 5000 spermatozoa were analysed. The output was a DFI, the percentage of fragmented sperm DNA calculated from the DFI frequency histogram obtained from the ratio between the red and total [red plus green] fluorescence intensity with dedicated software. The neutral Comet assay detects double-stranded DNA breaks by exploiting the electrophoretic mobilisation of DNA fragments from nuclei after chromatin decondensation obtained by treatment with high-salt and disulphide-reducing agents. Approximately 150 sperm were analysed in each sample. For each cell, the value of tail intensity [% TI; i.e. the ratio of DNA migrated to the tail of the comet, to total DNA] was analysed, and the mean TI was calculated for each individual. We also calculated the percentage of damaged sperm, where sperm in which more than 10% of the DNA had migrated to the tail [i.e. TI >10%] were considered as damaged. This value identifies cells in which no DNA migration was observed microscopically. 
Blood analyses
Thiopurine analyses
Concentrations of 6-TGN and 6-MeMP in blood plasma were determined with hot acid hydrolysis followed by ultra-performance liquid chromatography, essentially as described by Shipkova. 21 Metabolites in the blood were normalised to Hb. DNA-TGN in whole blood DNA and in spermatozoa was measured essentially as described by Jacobsen et al. 22 A subgroup of IBD patients delivered sperm and blood samples on the day of ingestion of their usual AZA dose. Two patients collected samples 0.5 h after ingestion, another two after 1 h, 1.5 h, and 2 h. Blood and seminal plasma 6-MP concentrations were measured with a validated reverse phase ultra-performance liquid chromatography-tandem mass spectrometry method using a Waters BEH C18 column and a water:acetonitrile 0.1% formic acid buffer system. A stable isotope internal standard [
13
C
15 N 2 6-MP] was employed to correct the matrix effects relative to calibrators made from spiked control blood plasma.
Statistical analysis
Categorical and continuous variables are depicted as absolute numbers with percentages and medians with range, respectively. Fisher's exact test for binary data and non-paired Wilcoxon rank sum test for continuous data were used for the group comparisons.
Data are presented as the mean with a 95% confidence interval [95% CI]. Where applicable, logarithmic transformation was applied to obtain normality, otherwise data were analysed non-parametrically when normality could not be obtained and presented as median with range. Unpaired sample t-tests were used to compare patients and healthy volunteers. We adjusted for age and abstinence duration [after logarithmic transformation], smoking status, and fever within 3 months of sampling, as potential confounders in a multiple linear regression model. Paired samples were analysed using paired sample t-test. Pearson's correlation coefficient was applied to examine the linear relationships between normally distributed data. Spearman's rank correlation was applied if normality could not be obtained. A p-value lower than 0.05 was regarded as statistically significant. Data were analysed using Stata version 13.1 [StataCorp LP, College Station, TX, USA]. Graphs were produced in Prism version 6.0 [GraphPad Software Inc., La Jolla, CA, USA]. A total of 10 IBD patients [six CD, four UC] delivered semen and blood samples both without and during AZA/6-MP treatment: eight patients before and after the start of treatment, and two patients before and after cessation of treatment. All patients starting thiopurines delivered follow-up samples after at least 3 months of treatment [median 4 months]. Both patients stopping treatment had been treated with thiopurines for more than 2 years, and their follow-up samples were collected more than 100 days after cessation of the drug. One CD patient had mild disease according to the HBI [HBI 5] before initiation of treatment; all other patients were in clinical remission both on and off treatment, according to the clinical disease indices HBI and SCCAI. Out of the six patients on anti-TNF-alpha treatment, four patients were concomitantly treated with infliximab and two patients with adalimumab at both sampling times. Two were treated with 5-ASA. Smoking habits and weight among the included patients did not change during the study period. In total, seven patients fathered nine children while on thiopurine treatment.
Ethics committee approval
Results
Study population
Sperm DNA fragmentation
Crude and adjusted differences in semen parameters are presented in Table 3 We did not see a statistically significant change in DFI when patients were off treatment compared with when they were on treatment [ Table 3 ; Figure 1 ], and only one patient had DFI levels above 20% on treatment. This particular patient also had a severely impaired sperm quality as evaluated by WHO parameters, both off and on AZA treatment. When evaluating DNA integrity by the Comet parameters, we found no statistically significant differences in the mean TI [p = 0.7] or the percentage of damaged sperm [p = 0.9] between IBD patients and healthy volunteers or between off and on samples [ Table 3 ; Figure 1 ].
WHO semen analyses
Compared with healthy volunteers, IBD patients had decreased sperm motility, evaluated by total motility [p = 0.0003], PR [p = 0.0004], and immotile spermatozoa [p = 0.0001, Table 3 ]. Neither sperm concentration nor sperm morphology differed between the groups. Because the healthy volunteers had no contact with the sperm bank before sampling, it was not possible to control the abstinence duration among the healthy volunteers. Following adjustment for abstinence duration, age, smoking status, and fever, or when excluding healthy volunteers with an abstinence duration under 2 days, we found no significant differences in semen volume or total sperm number between the groups [ Table 3 ]. The estimates did not change when restricting the analyses to patients on AZA/6-MP monotherapy [data not shown].
We observed a trend to increased motility, evaluated by percent total motile spermatozoa and PR, off treatment compared with on treatment, although the results were not statistically significant [ Table 3 ; Figure 1 ]. One individual showed the opposite pattern, with considerably higher motility on thiopurines than off, and thereby obscured the general picture and statistical significance. The paired samples revealed no differences in semen volume, sperm concentration, or morphology off and on AZA/6-MP treatment [ Table 3 ; Figure 1 ].
According to the WHO classification, all IBD patients on thiopurines had normal semen volume, and only two [5 
Thiopurine analyses in blood and spermatozoa
Therapeutic levels of erythrocyte [ery]-TGN were detected in blood, thus documenting that all patients were adherent to thiopurine therapy [ Table 4 ]. There was a statistically significant negative correlation between DNA-TGN levels in blood and PR [Pearson's r = -0.4, p = 0.03; Figure 2 ]. Analysis of DNA-TGN in spermatozoa was available in 37 IBD patients. As expected, all samples contained abundant amounts of DNA. Reassuringly, we could not detect DNA-TGN in spermatozoa. We found no correlation between the duration of AZA/6-MP treatment and semen quality [data not shown].
6-MP levels in blood and seminal plasma
Eight patients delivered samples immediately following AZA ingestion, for the measurement of 6-MP in blood and ejaculate. We detected 6-MP in all blood and seminal plasma samples after AZA intake [ Figure 3A] , and there was a statistically significant positive correlation between blood and seminal plasma levels [r s = 0.79, p = 0.02]. The 6-MP semen:blood ratio level varied between 0.2 and 5.6 and did not significantly increase with time [ Figure 3B ].
Sex hormone and inflammatory markers
The mean values of testosterone, LH, FSH, SHBG, and inhibin B were all within the normal range for patients on maintenance thiopurine therapy [ [ Table 4 ]. FCP was lower on treatment than off, although not statistically significantly so [median 254 mg/kg versus 83.0 mg/kg, p = 0.08].
Discussion
This is the first clinical study to investigate the influence of thiopurine treatment on sperm quality evaluated by both sperm DNA integrity and WHO semen parameters. In essence, we found no indications of increased sperm DNA strand break levels following thiopurine treatment when measured with both SCSA and Comet assay. This finding was corroborated in the paired samples from IBD patients off and on thiopurine treatment, where we observed no change in the level of sperm DNA fragmentation. Furthermore, we could not detect incorporation of TGN in sperm DNA. We found a significantly decreased sperm motility in IBD patients on AZA/6-MP compared with the healthy volunteers, and PR correlated negatively with DNA-TGN levels in blood. In individual IBD patients, this finding was supported by a trend to lower sperm motility on AZA/6-MP treatment compared with off treatment. Taken together, our findings indicate that the majority of our IBD patients have a normal semen quality and that the use of thiopurines does not negatively affect sperm DNA integrity but may impair sperm motility. In this study, semen quality and male endocrine function were evaluated using validated state-of-the-art methods, and we used two different methods to evaluate sperm DNA integrity. All WHO analyses were performed in the same laboratory. 23 We measured thiopurine serum metabolites to ensure drug adherence, and we were able to compare semen quality off and on AZA/6-MP treatment in a subgroup of IBD patients. Moreover, all patients on maintenance treatment were in clinical remission according to established clinical disease activity indices. FCP levels were below 250 mg/kg in the majority of patients and were lower on AZA/6-MP treatment. A potential effect on sperm quality from subclinical inflammation therefore seems unlikely. 24, 25 Our observations in this clinical cohort of IBD patients are supported by epidemiological studies of reproductive outcomes following paternal thiopurine treatment. In a meta-analysis, Simsek et al. 7 found no significantly increased risk of congenital abnormalities in exposed offspring. Similarly, Nørgaard et al. 26 found no increased risk of preterm birth or small size for gestational age following paternal AZA/6-MP exposure.
Infertile men have more sperm DNA damage than fertile men, 12 and an abnormal amount of sperm DNA fragmentation has a negative impact on pregnancy rates and unexplained recurrent miscarriage. 13, 27 We did not see a higher level of sperm DNA fragmentation evaluated by either the SCSA or the Comet assay in IBD patients on AZA/6-MP maintenance treatment compared with healthy volunteers, and the majority of participants had DFI levels well below 20%. The lack of difference in the paired samples off and on AZA/6-MP supports these findings. A plausible explanation for the unchanged sperm DNA fragmentation levels in spermatozoa is the protective role of the blood-testis barrier, and the undetectable levels of DNA-TGN incorporation in spermatozoa are further reassuring. 28 This study could be underpowered to detect a statistically significant difference in sperm DNA fragmentation, but the DFI levels measured in our cohorts are comparable to those in previous studies of the general population. 29 Further, the small DFI changes observed in the paired samples are not clinically relevant. 12 For comparison, a recent case-control study found significantly increased DFI levels in six IBD patients treated with methotrexate compared with male partners of couples seeking fertility treatment [mean DFI 25% versus 16.1%, p ≤ 0.0001]. 30 Our finding of reduced sperm motility is likely explained by the presence of 6-MP in seminal plasma. The flagellar movement of the spermatozoon is driven by ATP. 31 In vitro, ATP depletion was observed in human somatic cell lines after incubation with thiopurines in pharmacologically relevant doses. 32 This could imply that the presence of 6-MP diminishes ATP levels in the spermatozoa, either during the transit in the epididymis, where sperm become motile, or upon ejaculation. Thiopurine treatment did not affect sex hormone levels, and hormone levels did not change off versus on treatment, lending further evidence that the effect of AZA/6-MP is a local toxic effect on spermatozoa. 33, 34 Few previous studies have examined the effects of thiopurine treatment on standard WHO parameters. In a recent cross-sectional study, there were no differences in sperm concentration, total motility, or morphology between IBD patients on thiopurines and patients off. 35 Dejaco et al. 36 performed semen analysis on 18 IBD patients treated with AZA for at least 3 months. In favour of our study, sperm motility was decreased in 33% of the samples. In the same study, sperm samples were obtained before and during AZA therapy in 10 patients and after long-term treatment in additional five patients [49 ± 14 months], without significant differences in WHO semen parameters.
WHO semen analysis has a limited value for predicting the chance of natural conception, and there is a significant overlap between fertile and infertile men. 37 Normal sperm morphology and sperm concentration are associated with the likelihood of pregnancy, whereas motility and volume are of limited value in pregnancy prediction in couples with unknown fertility. 38 The clinical significance of reduced motility found in our AZA/6-MP-treated IBD cohort is therefore partly unknown, and does not necessarily lead to a reduced fecundity, let alone an increased risk of adverse pregnancy outcomes. However, it is reassuring that nine children were born after paternal thiopurine exposure. 
